ArticleMolecular pharmaceutics2026
Revisiting the LSER Approach in the Era of Machine Learning: Insights from IAM Chromatography.
Article in Molecular pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The present study demonstrates the integration of the linear solvation energy relationship (LSER) concept with machine learning (ML) methodologies to improve the predictive and interpretative capabilities of chromatographic retention modeling. Immobilized artificial membrane (IAM) chromatography was employed as a model biochromatographic system, and an in-house library of 993 structurally diverse compounds, with experimentally determined chromatographic hydrophobicity index of IAM (CHIIAM), was used to train LSER-ML models. LSER descriptors were calculated using Absolv and extended with ionization-state descriptors to evaluate the applicability of the LSER framework for realistic in silico virtual screening scenarios. Several regression algorithms were tested, including linear, neighborhood-based, kernel-based, and ensemble tree-based models. Among them, the support vector regression with the radial basis function kernel (SVR-RBF) demonstrated the most balanced performance across all validation metrics of R2train = 0.884, R2test = 0.853, and Q2cv = 0.811, achieving predictive errors (RMSEtrain = 5.546, RMSEtest = 4.609, and RMSEcv = 6.989) close to the analytical uncertainty. Model interpretability was achieved using SHapley Additive exPlanations (SHAP), which confirmed the mechanistic relevance of the Abraham descriptors and the dominant contribution of hydrophobic volume and hydrogen-bonding properties to IAM retention. Applicability domain was verified with a Williams plot (±3 standardized residuals and leverage threshold h*). The results indicate that the proposed LSER-ML approach provides an interpretable, robust, and generalizable tool for modeling membrane-mimetic chromatographic systems and can be effectively applied in virtual screening and property-based molecular design.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.